Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114715) titled 'Clinical study of individualized bacteriophage therapy for respiratory tract infections caused by antibiotic-resistant bacteria' on Dec. 17, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Wuhan Jinyintan Hospital
Condition:
Drug-resistant bacterial respiratory infections
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-18
Target Sample Size: Experimental Group:108;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=301001
Published by HT Digital Content Services with permission from Healt...